And there you have it;
”This combination study will run in parallel with the phase 2 DEP® docetaxel trial program, which is currently recruiting at sites in the UK“.
So the never-ending Phase 2 trial which was supposed to be finished in the first half of CY2020 is actually still recruiting. It’s not going to end anytime soon. Maybe the Quarterly Report will shed some more light on the trial and revised timeframe.
- Forums
- ASX - By Stock
- Ann: DEP docetaxel and gemcitabine combination trial commences
And there you have it;”This combination study will run in...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.64M |
Open | High | Low | Value | Volume |
9.7¢ | 9.7¢ | 9.5¢ | $19.64K | 204.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 69731 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.7¢ | 5390 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 69731 | 0.095 |
2 | 305855 | 0.094 |
2 | 320000 | 0.093 |
1 | 100000 | 0.092 |
4 | 49861 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.097 | 5390 | 1 |
0.098 | 200000 | 1 |
0.100 | 106000 | 3 |
0.105 | 148467 | 3 |
0.110 | 183058 | 5 |
Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |